GENB - Generate Biomedicines, Inc.
Price:
--
--
Market Cap:
1.46B
Volume:
298,009
Avg Volume:
1,104,112
52 Week Range:
11-15.32
Sector:
Financial Services
Industry:
Asset Management
Beta:
N/A
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
312
IPO Date:
2026-02-27
EPS (TTM):
-4.98
P/E Ratio:
-3.12
Revenue (TTM):
31.89M
Total Assets:
330.18M
Total Debt:
68.53M
Cash & Equiv:
121.65M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-89.4%
Debt/Equity:
-0.11
| Metric | 2025 | 2024 |
|---|---|---|
| Revenue | 31.89M | 20.46M |
| Net Income | (203.15M) | (173.77M) |
| EPS | -4.98 | -1.68 |
| Total Assets | 330.18M | 518.26M |
| Total Debt | 68.53M | 76.97M |
| Cash & Equivalents | 121.65M | 176.27M |
| Operating Cash Flow | (200.62M) | (117.75M) |
| Free Cash Flow | (204.13M) | (121.20M) |
| FCF per Share | -4.08 | -0.95 |
| Book Value | (615.97M) | (434.52M) |
| Cash & ST Investments | 221.50M | 393.63M |
| ROC Equity | N/A | N/A |